biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Jan 27, 2017 3:13pm

151 Views

Post# 25765396

RE:RE:RE:RE:RE:RE:Countering Defeatism from Beenthere and Others

You don't need imagination to understand that BiOasis is on the verge of being able to treat an unmet medical need, in which it's market is estimated to be in the order of 200 Billion. I don't need imagination to understand that only a sliver of that pie will send us to the moon. Small minded thinkers are unable to get their heads around the fact that the sp is stuck here. It won't be forever, and all indications are that deals will be signed off on soon. Have none of you talked to management? Are they lying? I highly doubt it given the results we've seen from third party studies. Wake up! Sniper

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario